Certifications 2

SDS No.: 153555 V002.0
LOCTITE 406/770 TAK PAK
Page 3 of 15
Declaration of the ingredients according to CLP (EC) No 1272/2008:
Hazardous components
CAS-No.
EC Number
REACH-Reg No.
content
Classification
n-Heptane
142-82-5
205-563-8
01-2119457603-38
50- 100 %
Flam. Liq. 2
H225
Asp. Tox. 1
H304
Skin Irrit. 2
H315
STOT SE 3
H336
Aquatic Acute 1
H400
Aquatic Chronic 1
H410
Methylcyclohexane
108-87-2
203-624-3
0,1- < 1 %
Flam. Liq. 2
H225
Asp. Tox. 1
H304
Skin Irrit. 2
H315
STOT SE 3
H336
Aquatic Acute 1
H400
Aquatic Chronic 1
H410
1,8-Diazabicyclo[5.4.0]undec-7-ene
6674-22-2
229-713-7
01-2119977097-24
0,1- < 1 %
Acute Tox. 3; Oral
H301
Skin Corr. 1B
H314
For full text of the H - statements and other abbreviations see section 16 "Other information".
Substances without classification may have community workplace exposure limits available.
SECTION 4: First aid measures
4.1. Description of first aid measures
Inhalation:
Move to fresh air. If symptoms persist, seek medical advice.
Skin contact:
Rinse with running water and soap.
Obtain medical attention if irritation persists.
Eye contact:
Rinse immediately with plenty of running water (for 10 minutes), seek medical attention from a specialist.
Ingestion:
Rinse mouth, drink 1-2 glasses of water, do not induce vomiting, consult a doctor.
4.2. Most important symptoms and effects, both acute and delayed
SKIN: Redness, inflammation.
ASPIRATION: Coughing, shortness of breath, nausea. Delayed effect: bronchopneumonia or pulmonary oedema
Vapors may cause drowsiness and dizziness.
Prolonged or repeated contact may cause eye irritation.